Cargando…
Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study
Background: Lung cancer is the most common cause of cancer-related deaths worldwide. Early diagnosis is crucial to increase the curability chance of the patients. Low dose CT screening can reduce lung cancer mortality, but it is associated with several limitations. Metabolomics is a promising techni...
Autores principales: | Singhal, Sandeep, Rolfo, Christian, Maksymiuk, Andrew W., Tappia, Paramjit S., Sitar, Daniel S., Russo, Alessandro, Akhtar, Parveen S., Khatun, Nazrina, Rahnuma, Parveen, Rashiduzzaman, Ahmed, Ahmed Bux, Rashid, Huang, Guoyu, Ramjiawan, Bram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721278/ https://www.ncbi.nlm.nih.gov/pubmed/31362354 http://dx.doi.org/10.3390/cancers11081069 |
Ejemplares similares
-
Use of amantadine as substrate for SSAT-1 activity as a reliable clinical diagnostic assay for breast and lung cancer
por: Maksymiuk, Andrew W, et al.
Publicado: (2018) -
Predictive value and clinical significance of increased SSAT-1 activity in healthy adults
por: Tappia, Paramjit S, et al.
Publicado: (2019) -
Use of amantadine in the evaluation of response to chemotherapy in lung cancer: a pilot study
por: Maksymiuk, Andrew W, et al.
Publicado: (2021) -
Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome
por: Haince, Jean-François, et al.
Publicado: (2022) -
Spermidine/spermine N1-acetyltransferase-1 as a diagnostic biomarker in human cancer
por: Maksymiuk, Andrew W, et al.
Publicado: (2018)